Follow
Justin Taft
Justin Taft
Dispatch Biotherapeutics
Verified email at dispatchbio.com
Title
Cited by
Cited by
Year
Trimeric HIV-1-Env structures define glycan shields from clades A, B, and G
GBE Stewart-Jones, C Soto, T Lemmin, GY Chuang, A Druz, R Kong, ...
Cell 165 (4), 813-826, 2016
4122016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
R Kong, K Xu, T Zhou, P Acharya, T Lemmin, K Liu, G Ozorowski, C Soto, ...
Science 352 (6287), 828-833, 2016
3312016
Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes
R Kong, MK Louder, K Wagh, RT Bailer, A deCamp, K Greene, H Gao, ...
Journal of virology 89 (5), 2659-2671, 2015
1382015
Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy
C Gruber, M Martin-Fernandez, F Ailal, X Qiu, J Taft, J Altman, J Rosain, ...
Journal of Experimental Medicine 217 (5), 2020
902020
Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death
J Taft, M Markson, D Legarda, R Patel, M Chan, L Malle, A Richardson, ...
Cell 184 (17), 4447-4463. e20, 2021
792021
A neutralizing antibody recognizing primarily N-linked glycan targets the silent face of the HIV envelope
T Zhou, A Zheng, U Baxa, GY Chuang, IS Georgiev, R Kong, S O’Dell, ...
Immunity 48 (3), 500-513. e6, 2018
792018
An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
S Tanaka, G Nelson, CA Olson, O Buzko, W Higashide, A Shin, ...
Scientific Reports 11 (1), 12740, 2021
582021
Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing
A Park, P Hong, ST Won, PA Thibault, F Vigant, KY Oguntuyo, JD Taft, ...
Molecular therapy Methods & clinical development 3, 2016
522016
A partial form of inherited human USP18 deficiency underlies infection and inflammation
M Martin-Fernandez, S Buta, T Le Voyer, Z Li, LT Dynesen, F Vuillier, ...
Journal of Experimental Medicine 219 (4), e20211273, 2022
362022
The Goldilocks zone of type I IFNs: lessons from human genetics
J Taft, D Bogunovic
The Journal of Immunology 201 (12), 3479-3485, 2018
332018
Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cells
L Malle, RS Patel, M Martin-Fernandez, OJ Stewart, Q Philippot, S Buta, ...
Nature 615 (7951), 305-314, 2023
292023
ISG15 deficiency restricts HIV-1 infection
D Jurczyszak, L Manganaro, S Buta, C Gruber, M Martin-Fernandez, J Taft, ...
PLoS Pathogens 18 (3), e1010405, 2022
162022
Dioxin Exposure Alters Molecular and Morphological Responses to Thyroid Hormone in Xenopus laevis Cultured Cells and Prometamorphic Tadpoles
JD Taft, MM Colonnetta, RE Schafer, N Plick, WH Powell
Toxicological Sciences 161 (1), 196-206, 2018
162018
Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display
S Tanaka, CA Olson, CO Barnes, W Higashide, M Gonzalez, J Taft, ...
Cell Reports 38 (6), 2022
142022
Prime hAd5 spike+ nucleocapsid vaccination induces ten-fold increases in mean T-cell responses in phase 1 subjects that are sustained against spike variants
P Sieling, T King, R Wong, A Nguyen, K Wnuk, E Gabitzsch, A Rice, ...
medRxiv, 2021.04. 05.21254940, 2021
142021
Type I IFN is siloed in endosomes
JB Altman, J Taft, T Wedeking, CN Gruber, M Holtmannspötter, J Piehler, ...
Proceedings of the National Academy of Sciences 117 (30), 17510-17512, 2020
142020
Developing Broad-Spectrum Antivirals Using Porcine and Rhesus Macaque Models
X Qiu, J Taft, D Bogunovic
The Journal of Infectious Diseases 221 (6), 890-894, 2020
52020
Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
CA Cottrell, K Manne, R Kong, S Wang, T Zhou, GY Chuang, RJ Edwards, ...
Cell reports 37 (5), 2021
42021
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challenge
A Pegu, SE Lovelace, ME DeMouth, MD Cully, DJ Morris, Y Li, K Wang, ...
Science Translational Medicine 16 (730), eadh9039, 2024
22024
Plasticity of the Type-I Interferon System Demonstrated by a Developing Antiviral and a Novel Inborn Error of Immunity
J Taft
Icahn School of Medicine at Mount Sinai, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20